Altre lingue Bio-Techne Corporation

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 06/05/2024			Variaz. 5gg	Var. 1 gen.
76,06 ^USD	-1,59%		+17,90%	-1,43%

06/05	BIO-TECHNE CORPORATION : Argus è per il Buy	ZM
02/05	BIO-TECHNE CORPORATION : giudizio positivo da UBS	ZM

Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Top Midday Gainers	01/05
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	01/05
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	01/05
Bio-Techne Shares Jump After Fiscal Q3 Beat	01/05
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	01/05
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	01/05
BIO-TECHNE DECLARES DIVIDEND	01/05
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS	01/05
Bio-Techne Corporation Declares Dividend for the Quarter Ended March 31, 2024, Payable on May 24, 2024	01/05
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS	30/04
Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	30/04
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	29/04
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC	29/04
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	29/04
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26/04
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	26/04
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	23/04
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23/04

Non ci sono risultati per questa ricerca